Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials ; volume:9 ; number:1 ; day:8 ; month:11 ; year:2018 ; pages:1-9 ; date:12.2018
Stem cell research & therapy ; 9, Heft 1 (8.11.2018), 1-9, 12.2018
- Urheber
-
Kleiderman, Erika
Boily, Audrey
Hasilo, Craig
Knoppers, Bartha Maria
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-018-1055-2
- URN
-
urn:nbn:de:101:1-2018122701024885312851
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kleiderman, Erika
- Boily, Audrey
- Hasilo, Craig
- Knoppers, Bartha Maria
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sample size calculation in multi-centre clinical trials
Overcoming the barriers to better evidence generation from clinical trials
Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
Overcoming Historicism
Overcoming Historicism
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
Regenerative supply chains : = Regenerative Wertschöpfungsketten
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Promising advances in clinical trials of dental tissue-derived cell-based regenerative medicine
Overcoming Culture Clash
Sample size calculation in multi-centre clinical trials
Overcoming the barriers to better evidence generation from clinical trials
Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
Overcoming Historicism
Overcoming Historicism
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
Regenerative supply chains : = Regenerative Wertschöpfungsketten
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Promising advances in clinical trials of dental tissue-derived cell-based regenerative medicine
Overcoming Culture Clash
Sample size calculation in multi-centre clinical trials
Overcoming the barriers to better evidence generation from clinical trials
Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
Overcoming Historicism
Overcoming Historicism
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
Regenerative supply chains : = Regenerative Wertschöpfungsketten
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Promising advances in clinical trials of dental tissue-derived cell-based regenerative medicine